Effect of dexmedetomidine combined with etomidate on IL‑17A and S‑100&beta; expression levels in rats with postoperative cognitive dysfunction

Yu,Xiaoli; Xie,Yunfang

doi:10.3892/etm.2020.9405

Effect of dexmedetomidine combined with etomidate on IL‑17A and S‑100β expression levels in rats with postoperative cognitive dysfunction

Authors:
- Xiaoli Yu
- Yunfang Xie
View Affiliations

Affiliations: Department of Anesthesiology, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: October 27, 2020 https://doi.org/10.3892/etm.2020.9405
Article Number: 275

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to explore the effects of dexmedetomidine combined with etomidate on the expression levels of interleukin (IL)‑17A and S‑100β in rats with postoperative cognitive dysfunction (POCD). A total of 50 SD rats were randomly allocated into the control group, model group, etomidate group (Eto group), dexmedetomidine group (Dex group) and dexmedetomidine combined with etomidate group (Dex‑Eto group). Inhalation anesthesia was used in all five groups. Apart from the control group, partial lobectomy was performed to construct a rat model of cognitive dysfunction. The rats of the model group received no intravenous anesthesia, except general anesthesia with intubation. Morris water maze test was performed before injection (T₀), at the 1st day (T₁), the 3rd day (T₂) and the 5th day (T₃) after operation to assess the memory ability of the rats. At the end of T3, the expression levels of IL‑17A, S‑100β, TNF‑α, IL‑6 and IL‑1β in serum were detected by ELISA and the expression of NF‑κB p65 by western blot analysis. Compared with the control group, the model group showed an increased escape latency and swimming distance, decreased number of times of crossing the platform and target quadrant residence time, and increased expression levels of IL‑17A, S‑100β, TNF‑α, IL‑6, IL‑1β and NF‑κB p65. Compared with the model group, the escape latency and swimming distance in the Dex, Eto and Dex‑Eto groups were reduced, whereas the number of times of crossing the platform and the target quadrant residence time were increased. In addition, the expression levels of IL‑17A, S‑100β, TNF‑α, IL‑6, IL‑1β and NF‑κB p65 were decreased in the Dex, Eto and Dex‑Eto groups, compared with the model group. Among the Dex, Eto and Dex‑Eto groups, the escape latency and swimming distance in the Dex‑Eto group were the shortest, the number of times of crossing the platform and the target quadrant residence time were the highest, and IL‑17A, S‑100β, TNF‑α, IL‑6, IL‑1β and NF‑κB p65 expression levels were the lowest. In conclusion, dexmedetomidine combined with etomidate can effectively improve POCD.

View Figures

View References

1	Zhou C, Zhu Y, Liu Z and Ruan L: Effect of dexmedetomidine on postoperative cognitive dysfunction in elderly patients after general anaesthesia: A meta-analysis. J Int Med Res. 44:1182–1190. 2016.PubMed/NCBI View Article : Google Scholar
2	Qian XL, Zhang W, Liu MZ, Zhou YB, Zhang JM, Han L, Peng YM, Jiang JH and Wang QD: Dexmedetomidine improves early postoperative cognitive dysfunction in aged mice. Eur J Pharmacol. 746:206–212. 2015.PubMed/NCBI View Article : Google Scholar
3	Sprung J, Roberts RO, Weingarten TN, Nunes Cavalcante A, Knopman DS, Petersen RC, Hanson AC, Schroeder DR and Warner DO: Postoperative delirium in elderly patients is associated with subsequent cognitive impairment. Br J Anaesth. 119:316–323. 2017.PubMed/NCBI View Article : Google Scholar
4	Wang WX, Wu Q, Liang SS, Zhang XK, Hu Q, Chen QH, Huang HJ, Xu L and Lou FQ: Dexmedetomidine promotes the recovery of neurogenesis in aged mouse with postoperative cognitive dysfunction. Neurosci Lett. 677:110–116. 2018.PubMed/NCBI View Article : Google Scholar
5	Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, Takata M, Lever IJ, Nanchahal J, Fanselow MS and Maze M: Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol. 68:360–368. 2010.PubMed/NCBI View Article : Google Scholar
6	Wright CB, Sacco RL, Rundek T, Delman J, Rabbani L and Elkind M: Interleukin-6 is associated with cognitive function: The northern manhattan study. J Stroke Cerebrovasc Dis. 15:34–38. 2006.PubMed/NCBI View Article : Google Scholar
7	Terrando N, Monaco C, Ma D, Foxwell BMJ, Feldmann M and Maze M: Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci USA. 107:20518–20522. 2010.PubMed/NCBI View Article : Google Scholar
8	Alam A, Hana Z, Jin Z, Suen KC and Ma D: Surgery, neuroinflammation and cognitive impairment. EBioMedicine. 37:547–556. 2018.PubMed/NCBI View Article : Google Scholar
9	Ma X, Reynolds SL, Baker BJ, Li X, Benveniste EN and Qin H: IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J Immunol. 184:4898–4906. 2010.PubMed/NCBI View Article : Google Scholar
10	Zuo Y, Zhao L, Zeng M, Yang Q, Chen X and Yang T: The effects of vitamin-rich carbohydrate pretreatment on the surgical stress response and S-100β after splenectomy in elderly rats. BMC Anesthesiol. 19(77)2019.PubMed/NCBI View Article : Google Scholar
11	Mercier E, Boutin A, Lauzier F, Fergusson DA, Simard JF, Zarychanski R, Moore L, McIntyre LA, Archambault P, Lamontagne F, et al: Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: Systematic review and meta-analysis. BMJ. 346(f1757)2013.PubMed/NCBI View Article : Google Scholar
12	Li Y, He R, Chen S and Qu Y: Effect of dexmedetomidine on early postoperative cognitive dysfunction and peri-operative inflammation in elderly patients undergoing laparoscopic cholecystectomy. Exp Ther Med. 10:1635–1642. 2015.PubMed/NCBI View Article : Google Scholar
13	Xiang H, Hu B, Li Z and Li J: Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Inflammation. 37:1763–1770. 2014.PubMed/NCBI View Article : Google Scholar
14	Zhu YJ, Peng K, Meng XW and Ji FH: Attenuation of neuroinflammation by dexmedetomidine is associated with activation of a cholinergic anti-inflammatory pathway in a rat tibial fracture model. Brain Res. 1644:1–8. 2016.PubMed/NCBI View Article : Google Scholar
15	Monk TG and Price CC: Postoperative cognitive disorders. Curr Opin Crit Care. 17:376–381. 2011.PubMed/NCBI View Article : Google Scholar
16	Sanders RD, Xu J, Shu Y, Januszewski A, Halder S, Fidalgo A, Sun P, Hossain M, Ma D and Maze M: Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology. 110:1077–1085. 2009.PubMed/NCBI View Article : Google Scholar
17	Li X, Lu F, Li W, Xu J, Sun XJ, Qin LZ, Zhang QL, Yao Y, Yu QK and Liang XL: Underlying mechanisms of memory deficits induced by etomidate anesthesia in aged rat model: Critical role of immediate early genes. Chin Med J (Engl). 129:48–53. 2016.PubMed/NCBI View Article : Google Scholar
18	Liu M, Zhang Y, Xiong JY, Wang Y and Lv S: Etomidate mitigates lipopolysaccharide-induced CD14 and TREM-1 expression, NF-κB activation, and pro-inflammatory cytokine production in rat macrophages. Inflammation. 39:327–335. 2016.PubMed/NCBI View Article : Google Scholar
19	Clark JD, Gebhart GF, Gonder JC, Keeling ME and Kohn DF: Special report: The 1996 guide for the care and use of laboratory animals. ILAR J. 38:41–48. 1997.PubMed/NCBI View Article : Google Scholar
20	Kishikawa H, Kobayashi K, Takemori K, Okabe T, Ito K and Sakamoto A: The effects of dexmedetomidine on human neutrophil apoptosis. Biomed Res. 29:189–194. 2008.PubMed/NCBI View Article : Google Scholar
21	Yu H, Dong R, Lu Y, Yang X, Chen C, Zhang Z and Peng M: Short-term postoperative cognitive dysfunction and inflammatory response in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A pilot study. Mediators Inflamm. 2017(3605350)2017.PubMed/NCBI View Article : Google Scholar
22	Giannoudis PV, Dinopoulos H, Chalidis B and Hall GM: Surgical stress response. Injury. 37 (Suppl 5):S3–S9. 2006.PubMed/NCBI View Article : Google Scholar
23	Kolls JK and Lindén A: Interleukin-17 family members and inflammation. Immunity. 21:467–476. 2004.PubMed/NCBI View Article : Google Scholar
24	Schaf DV, Tort AB, Fricke D, Schestatsky P, Portela LVC, Souza DO and Rieder CRM: S100B and NSE serum levels in patients with Parkinson's disease. Parkinsonism Relat Disord. 11:39–43. 2005.PubMed/NCBI View Article : Google Scholar
25	Yardan T, Cevik Y, Donderici O, Kavalci C, Yilmaz FM, Yilmaz G, Vural K, Yuzbasioglu Y, Gunaydin YK and Sezer AA: Elevated serum S100B protein and neuron-specific enolase levels in carbon monoxide poisonin. Am J Emerg Med. 27:838–842. 2009.PubMed/NCBI View Article : Google Scholar
26	Xiong B, Shi Q and Fang H: Dexmedetomidine alleviates postoperative cognitive dysfunction by inhibiting neuron excitation in aged rats. Am J Transl Res. 8:70–80. 2016.PubMed/NCBI
27	Chen J, Yan J and Han X: Dexmedetomidine may benefit cognitive function after laparoscopic cholecystectomy in elderly patients. Exp Ther Med. 5:489–494. 2013.PubMed/NCBI View Article : Google Scholar
28	Baughman VL, Hoffman WE, Miletich DJ and Albrecht RF: Cerebral metabolic depression and brain protection produced by midazolam and etomidate in the rat. J Neurosurg Anesthesiol. 1:22–28. 1989.PubMed/NCBI View Article : Google Scholar
29	Yang Z and Yuan C: IL-17A promotes the neuroinflammation and cognitive function in sevoflurane anesthetized aged rats via activation of NF-κB signaling pathway. BMC Anesthesiol. 18(147)2018.PubMed/NCBI View Article : Google Scholar
30	Tan J, Shen J, Gong Y and Zhu H: Dexmedetomidine ameliorates lipopolysaccharide-induced endothelial barrier disruption and inflammation by inhibiting NF-κB activity and activating α2-adrenergic receptor. Int J Clin Exp Med. 10:532–539. 2017.